透析起始时甲状旁腺激素水平决定后续继发性甲旁亢控制风险
基于21国5683例新发血液透析患者的前瞻性队列研究,按透析起始前即刻测定的甲状旁腺激素(PTH)分层,评估起始后第一年活性维生素D和拟钙剂使用及9-12个月PTH>600 pg/mL的风险。起始前PTH>600 pg/mL者占16%,其9-12个月PTH>600 pg/mL的患病率为29%,显著高于起始PTH 150-300 pg/mL者的7%(调整风险差19%,95%CI 15%-23%)。
要点
- 透析起始前PTH>600 pg/mL者占16%,后续PTH控制更差。
- 起始PTH>600者9-12个月PTH>600风险较150-300者高19%。
- 尽管活性维生素D和拟钙剂使用更多,高PTH仍持续。
核心结论
- 透析起始前PTH升高预测9-12个月后PTH水平更高,尽管活性维生素D和拟钙剂使用更多。
研究设计与样本
- 透析预后与实践模式研究(DOPPS)第4-6期(2009-18)前瞻性队列,纳入21国5683例新发血液透析患者。
主要发现
- 起始前PTH>600 pg/mL者占16%,第一年活性维生素D和拟钙剂处方更普遍。
- 起始PTH>600 pg/mL者9-12个月PTH>600 pg/mL患病率为29%,起始PTH 150-300 pg/mL者为7%。
- 调整风险差为19%(95%CI 15%-23%)。
- 9-12个月持续PTH>600 pg/mL者更年轻、黑人比例更高、透析起始时血磷和eGFR更高。
临床怎么用
- 非透析慢性肾脏病期间应更积极控制PTH,可能影响透析后结局。
- 提示需要制定非透析CKD患者的PTH目标指南。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Optimal parathyroid hormone (PTH) control during non-dialysis chronic kidney disease (ND-CKD) might decrease the subsequent risk of parathyroid hyperplasia and uncontrolled secondary hyperparathyroidism (SHPT) on dialysis. However, the evidence for recommending PTH targets and therapeutic strategies is weak for ND-CKD. We evaluated the patient characteristics, treatment patterns and PTH control over the first year of haemodialysis (HD) by PTH prior to HD initiation. METHODS: We studied 5683 incident HD patients from 21 countries in Dialysis Outcomes and Practice Patterns Study Phases 4-6 (2009-18). We stratified by PTH measured immediately prior to HD initiation and reported the monthly prescription prevalence of active vitamin D and calcimimetics over the first year of HD and risk of PTH >600 pg/mL after 9-12 months on HD. RESULTS: The 16% of patients with PTH >600 pg/mL prior to HD initiation were more likely to be prescribed active vitamin D and calcimimetics during the first year of HD. The prevalence of PTH >600 pg/mL 9-12 months after start of HD was greater for patients who initiated HD with PTH >600 (29%) versus 150-300 (7%) pg/mL (adjusted risk difference: 19%; 95% confidence interval : 15%, 23%). The patients with sustained PTH >600 pg/mL after 9-12 months on HD were younger, more likely to be black, and had higher serum phosphorus and estimated glomerular filtration rates at HD initiation. CONCLUSIONS: Increased PTH before HD start predicted a higher PTH level 9-12 months later, despite greater use of active vitamin D and calcimimetics. More targeted PTH control during ND-CKD may influence outcomes during HD, raising the need for PTH target guidelines in these patients.
引用
- Tabibzadeh N, Karaboyas A, Robinson BM, et al. The risk of medically uncontrolled secondary hyperparathyroidism depends on parathyroid hormone levels at haemodialysis initiation. Nephrol Dial Transplant. 2021. PMID: 33068419. doi:10.1093/ndt/gfaa195
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。